Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies

Abstract As a naturally occurring cytolytic peptide, melittin (MLT) not only exhibits a potent direct tumor cell-killing effect but also possesses various immunomodulatory functions. MLT shows minimal chances for developing resistance and has been recognized as a promising broad-spectrum antitumor d...

Full description

Bibliographic Details
Main Authors: Xiang Yu, Siyu Jia, Shi Yu, Yaohui Chen, Chengwei Zhang, Haidan Chen, Yanfeng Dai
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-02223-4
_version_ 1797414104912101376
author Xiang Yu
Siyu Jia
Shi Yu
Yaohui Chen
Chengwei Zhang
Haidan Chen
Yanfeng Dai
author_facet Xiang Yu
Siyu Jia
Shi Yu
Yaohui Chen
Chengwei Zhang
Haidan Chen
Yanfeng Dai
author_sort Xiang Yu
collection DOAJ
description Abstract As a naturally occurring cytolytic peptide, melittin (MLT) not only exhibits a potent direct tumor cell-killing effect but also possesses various immunomodulatory functions. MLT shows minimal chances for developing resistance and has been recognized as a promising broad-spectrum antitumor drug because of this unique dual mechanism of action. However, MLT still displays obvious toxic side effects during treatment, such as nonspecific cytolytic activity, hemolytic toxicity, coagulation disorders, and allergic reactions, seriously hampering its broad clinical applications. With thorough research on antitumor mechanisms and the rapid development of nanotechnology, significant effort has been devoted to shielding against toxicity and achieving tumor-directed drug delivery to improve the therapeutic efficacy of MLT. Herein, we mainly summarize the potential antitumor mechanisms of MLT and recent progress in the targeted delivery strategies for tumor therapy, such as passive targeting, active targeting and stimulus-responsive targeting. Additionally, we also highlight the prospects and challenges of realizing the full potential of MLT in the field of tumor therapy. By exploring the antitumor molecular mechanisms and delivery strategies of MLT, this comprehensive review may inspire new ideas for tumor multimechanism synergistic therapy.
first_indexed 2024-03-09T05:28:18Z
format Article
id doaj.art-5fa19b5e281b4cd58808c1584714e112
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-03-09T05:28:18Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-5fa19b5e281b4cd58808c1584714e1122023-12-03T12:34:58ZengBMCJournal of Nanobiotechnology1477-31552023-11-0121112210.1186/s12951-023-02223-4Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategiesXiang Yu0Siyu Jia1Shi Yu2Yaohui Chen3Chengwei Zhang4Haidan Chen5Yanfeng Dai6State Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, Hainan UniversityHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges UniversityHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges UniversityHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges UniversityHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges UniversityThe First College of Clinical Medical Science, China Three Gorges UniversityState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, Hainan UniversityAbstract As a naturally occurring cytolytic peptide, melittin (MLT) not only exhibits a potent direct tumor cell-killing effect but also possesses various immunomodulatory functions. MLT shows minimal chances for developing resistance and has been recognized as a promising broad-spectrum antitumor drug because of this unique dual mechanism of action. However, MLT still displays obvious toxic side effects during treatment, such as nonspecific cytolytic activity, hemolytic toxicity, coagulation disorders, and allergic reactions, seriously hampering its broad clinical applications. With thorough research on antitumor mechanisms and the rapid development of nanotechnology, significant effort has been devoted to shielding against toxicity and achieving tumor-directed drug delivery to improve the therapeutic efficacy of MLT. Herein, we mainly summarize the potential antitumor mechanisms of MLT and recent progress in the targeted delivery strategies for tumor therapy, such as passive targeting, active targeting and stimulus-responsive targeting. Additionally, we also highlight the prospects and challenges of realizing the full potential of MLT in the field of tumor therapy. By exploring the antitumor molecular mechanisms and delivery strategies of MLT, this comprehensive review may inspire new ideas for tumor multimechanism synergistic therapy.https://doi.org/10.1186/s12951-023-02223-4MelittinImmunomodulatorySide effectsTumorMultimechanism
spellingShingle Xiang Yu
Siyu Jia
Shi Yu
Yaohui Chen
Chengwei Zhang
Haidan Chen
Yanfeng Dai
Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
Journal of Nanobiotechnology
Melittin
Immunomodulatory
Side effects
Tumor
Multimechanism
title Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
title_full Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
title_fullStr Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
title_full_unstemmed Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
title_short Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
title_sort recent advances in melittin based nanoparticles for antitumor treatment from mechanisms to targeted delivery strategies
topic Melittin
Immunomodulatory
Side effects
Tumor
Multimechanism
url https://doi.org/10.1186/s12951-023-02223-4
work_keys_str_mv AT xiangyu recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT siyujia recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT shiyu recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT yaohuichen recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT chengweizhang recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT haidanchen recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies
AT yanfengdai recentadvancesinmelittinbasednanoparticlesforantitumortreatmentfrommechanismstotargeteddeliverystrategies